BGI-Shenzhen Closes $118 Million Acquisition of Complete Genomics
BGI-Shenzhen, the world’s largest gene sequencing company, closed its $118 million acquisition of Complete Genomics. Complete Genomics is a Silicon Valley company that specializes in whole human genome sequencing. BGI purchased all of Complete's outstanding common shares at $3.15 each, and it will operate Complete as a wholly-owned subsidiary. Dr. Clifford Reid will remain its CEO. Note: ChinaBio® recently interviewed Jun Wang, PhD, CEO of BGI, who talked about the Complete acquisition and other matters. The interview will be published tomorrow. More details.... Share this with colleagues: // //  
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here